Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted protein degradation: A promise for undruggable proteins
Kusal T. G. Samarasinghe, Craig M. Crews
Cell chemical biology (2021) Vol. 28, Iss. 7, pp. 934-951
Open Access | Times Cited: 184

Showing 1-25 of 184 citing articles:

Strategies for designing proteolysis targeting chimaeras (PROTACs)
Shipeng He, Guoqiang Dong, Junfei Cheng, et al.
Medicinal Research Reviews (2022) Vol. 42, Iss. 3, pp. 1280-1342
Closed Access | Times Cited: 73
Overcoming Cancer Drug Resistance Utilizing PROTAC Technology
Matthew R. Burke, Alexis R. Smith, Guangrong Zheng
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 69
The roles of E3 ubiquitin ligases in cancer progression and targeted therapy
Chibuzo Sampson, Qiuping Wang, Wuxiyar Otkur, et al.
Clinical and Translational Medicine (2023) Vol. 13, Iss. 3
Open Access | Times Cited: 67
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 65
Aptamer-Based Targeted Protein Degradation
Yuan Liu, Xu Qian, Chunyan Ran, et al.
ACS Nano (2023) Vol. 17, Iss. 7, pp. 6150-6164
Open Access | Times Cited: 47
Interaction modules that impart specificity to disordered protein
Kateřina Čermáková, H. Courtney Hodges
Trends in Biochemical Sciences (2023) Vol. 48, Iss. 5, pp. 477-490
Open Access | Times Cited: 45
Induced protein degradation for therapeutics: past, present, and future
Hojong Yoon, Justine C. Rutter, Yen-Der Li, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 1
Open Access | Times Cited: 22
PROTACs: Current and Future Potential as a Precision Medicine Strategy to Combat Cancer
Kailee A. Rutherford, Kirk J. McManus
Molecular Cancer Therapeutics (2024) Vol. 23, Iss. 4, pp. 454-463
Open Access | Times Cited: 17
Targeting NRF2 to treat cancer
Jared Sivinski, Donna D. Zhang, Eli Chapman
Seminars in Cancer Biology (2021) Vol. 76, pp. 61-73
Open Access | Times Cited: 63
Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor
Tian Niu, Kailin Li, Jiang Li, et al.
European Journal of Medicinal Chemistry (2021) Vol. 228, pp. 114012-114012
Closed Access | Times Cited: 56
PROTAC degraders as chemical probes for studying target biology and target validation
Václav Nêmec, Martin P. Schwalm, Susanne Müller, et al.
Chemical Society Reviews (2022) Vol. 51, Iss. 18, pp. 7971-7993
Closed Access | Times Cited: 52
Exploring the target scope of KEAP1 E3 ligase-based PROTACs
Guangyan Du, Jie Jiang, Nathaniel J. Henning, et al.
Cell chemical biology (2022) Vol. 29, Iss. 10, pp. 1470-1481.e31
Open Access | Times Cited: 52
Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors
Liwen Hua, Qiuyue Zhang, Xinyue Zhu, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 12, pp. 8091-8112
Closed Access | Times Cited: 47
Emerging targeted protein degradation tools for innovative drug discovery: From classical PROTACs to the novel and beyond
Yue Zhong, Fanglian Chi, Hanyu Wu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 231, pp. 114142-114142
Closed Access | Times Cited: 40
A platform for the rapid synthesis of proteolysis targeting chimeras (Rapid-TAC) under miniaturized conditions
Le Guo, Yaxian Zhou, Xueqing Nie, et al.
European Journal of Medicinal Chemistry (2022) Vol. 236, pp. 114317-114317
Open Access | Times Cited: 40
Protein Phosphatase 5-Recruiting Chimeras for Accelerating Apoptosis-Signal-Regulated Kinase 1 Dephosphorylation with Antiproliferative Activity
Qiuyue Zhang, Xuexuan Wu, Hengheng Zhang, et al.
Journal of the American Chemical Society (2022) Vol. 145, Iss. 2, pp. 1118-1128
Closed Access | Times Cited: 40
Inducible Degradation of Oncogenic Nucleolin Using an Aptamer-Based PROTAC
Miao Chen, Ping Zhou, Yun Kong, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 2, pp. 1339-1348
Closed Access | Times Cited: 40
PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies
Nuwayo Ishimwe Sincere, Krishnan Anand, Sumel Ashique, et al.
Molecules (2023) Vol. 28, Iss. 10, pp. 4014-4014
Open Access | Times Cited: 37
Current advances and development strategies of orally bioavailable PROTACs
Shenxin Zeng, Yingqiao Ye, Heye Xia, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115793-115793
Closed Access | Times Cited: 35
Nucleic acid degradation as barrier to gene delivery: a guide to understand and overcome nuclease activity
Heyang Zhang, Jo Vandesompele, Kevin Braeckmans, et al.
Chemical Society Reviews (2023) Vol. 53, Iss. 1, pp. 317-360
Closed Access | Times Cited: 35
Optimization of PROTAC Ternary Complex Using DNA Encoded Library Approach
Qiuxia Chen, Chuan Liu, Wei Wang, et al.
ACS Chemical Biology (2023) Vol. 18, Iss. 1, pp. 25-33
Open Access | Times Cited: 29
Nano‐LYTACs for Degradation of Membrane Proteins and Inhibition of CD24/Siglec‐10 Signaling Pathway
Kun Wang, Albert Cheung Hoi Yu, Kewei Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 13
Open Access | Times Cited: 26
Application of Novel Degraders Employing Autophagy for Expediting Medicinal Research
Xiang Li, Qian Liu, Xin Xie, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 3, pp. 1700-1711
Closed Access | Times Cited: 23
Discovery of Novel PROTAC Degraders of p300/CBP as Potential Therapeutics for Hepatocellular Carcinoma
Qi Chang, Jiayi Li, Yue Deng, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 4, pp. 2466-2486
Closed Access | Times Cited: 12
The emerging roles of non-canonical ubiquitination in proteostasis and beyond
Yoshino Akizuki, Stephanie Kaypee, Fumiaki Ohtake, et al.
The Journal of Cell Biology (2024) Vol. 223, Iss. 5
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top